Epithalon: uses, evidence and status

compound file

The answer, first. A synthetic four-amino-acid peptide, Ala-Glu-Asp-Gly, designed at the St Petersburg Institute of Bioregulation and Gerontology in the 1990s from a bovine pineal extract called Epithalamin. The strongest evidence is for telomerase activity and telomere length, graded D — animal or mechanism only.

Epitalon lengthened telomeres dose-dependently in normal human cell lines by raising hTERT and telomerase activity, replicated independently at Brunel University in 2025 ⁵.

Both experiments are cell culture. No human telomere measurement exists ¹. Every other use — lifespan and tumour incidence, mortality in older adults, melatonin rhythm in older adults — grade D or E: animal or mechanism data with no controlled human outcome.

What it is used for

Every use graded on its own evidence, not the compound as a whole. 4 outcomes, ranked by what the human record supports.

#outcome · human · animal · gradewhat the best evidence actually shows

01Telomerase activity and telomere lengthno trial · cell culture plus mouse lifespan workgrade DEpitalon lengthened telomeres dose-dependently in normal human cell lines by raising hTERT and telomerase activity, replicated independently at Brunel University in 2025 ⁵. Both experiments are cell culture. No human telomere measurement exists ¹.

02Lifespan and tumour incidenceno trial · two mouse lifespan studiesgrade DIn 54 female SHR mice per arm dosed monthly for life, mean lifespan did not change ⁴. The last 10% of survivors lived 13.3% longer and leukaemia fell six-fold ⁴. Mouse data only.

03Mortality in older adultsnone of this peptide · mouse lifespan onlygrade DThe 1.6-to-1.8-fold mortality reduction quoted for this compound comes from Epithalamin, a bovine pineal extract given to 266 older adults over 6-8 years ². Different substance, unblinded, one institute ³.

04Melatonin rhythm in older adultsopen before-and-after, extract not peptide · rodent pineal workgrade DEpithalamin raised night-time plasma melatonin in older adults whose pineal output was already low, and lowered it in those with normal output ⁶. Open course, no control group, no participant count published.

gradewhat it means

ARegulatory approval, or multiple adequately-powered trials agreeing with each other

BAt least one well-powered human randomised trial, with the direction replicated

CSmall or open-label human trials only

DAnimal or mechanism data only, with no controlled human outcome

EA claim the human trials have already killed

How it works

The proposed mechanism, in three steps. A mechanism is a reason to run a trial, never a substitute for one.

1targetEpitalon is Ala-Glu-Asp-Gly, short enough to enter cells and bind DNA promoter regions directly rather than a surface receptor ⁷⁸.

2signalBinding is reported to raise hTERT transcription, restoring telomerase activity in somatic cells that had switched it off ¹⁵.

3effectTelomeres lengthen and cultured cells divide past their normal limit ⁹. Whether any of this happens in a person is untested.

What it does not do

Claims the current record does not support. Worth knowing before you set expectations.

not supported by the evidence

Epithalon extends human lifespan. No trial has given this peptide to people and counted deaths. The mortality figures belong to a different preparation ²³.
Epithalon lengthens telomeres in people. Telomere length has never been measured in a human given epitalon. Every telomere result is cell culture ¹⁵.
Western science replicated the human findings. One 2025 UK laboratory replicated the cell-culture telomere effect ⁵. No group outside St Petersburg has repeated the clinical work.
Safe because it is only four amino acids. Size does not establish safety. FDA flags immunogenicity and impurity risk and states it has no safety data for the proposed route ¹⁰.

How it is used

What published protocols administered, and what the community reports doing. Descriptive on both counts, and never a recommendation.

routeSubcutaneous injection is the near-universal route. Some product is sold as an intranasal spray or an oral capsule.

formatLyophilised powder in glass vials, reconstituted with bacteriostatic water.

published dosesNo human study dosed epitalon itself. The mouse lifespan work used 1 microgram per mouse, roughly 30-40 micrograms per kilogram, subcutaneously on five consecutive days each month for life ⁴. The human studies used intramuscular courses of Epithalamin, the extract, and published no per-kilogram dose ²³.

human pharmacokineticsNo human pharmacokinetic data published.

reported conventionsAs reported on peptide forums and vendor protocol pages, 2019-2026: a course of 10 to 20 consecutive days. Most often 5 to 10 mg daily, then months off before repeating. Course-and-pause rather than continuous use. Convention, not guidance.

commonly paired withPinealon Thymosin Alpha-1

This site does not publish protocols to follow. The doses above are what studies administered or what users report, stated as facts about the literature and the market. How protocols are structured, mixing and storage and the reconstitution calculator cover the arithmetic.

What to expect

Where a trial measured it, the trial. Where only the community reports it, that is said out loud.

onsetNo trial measured onset in humans. As reported: nothing perceptible during a first course for most people, with sleep quality the earliest thing anyone mentions. Because the claimed outcome is telomere length, there is no sensation that would confirm it either way.

most common reportAs reported: no felt effect at all. Sleep change is the common exception, and it is described inconsistently.

adverse effectsNo trial has published adverse event rates for this peptide. As reported: injection site soreness and occasional drowsiness. FDA lists epitalon among compounding substances that may present significant safety risks, citing immunogenicity and peptide impurities ¹⁰.

the stop signalAs reported: people stop at the end of a fixed course rather than on a signal, because there is nothing to measure. No published stopping rule exists.

Approval and status

What regulators and sport bodies have actually said, separately from what the evidence shows.

approvalNot approved anywhere. Sold as a research chemical.

FDAListed among bulk substances nominated for compounding then withdrawn, flagged for immunogenicity risk and no identified safety data.

sport [WADA]Not named on the List. Caught by S0, non-approved substances.

sold asresearch chemical

Check the vial

The grade above describes a molecule studied under controlled conditions. It says nothing about the powder in a particular vial.

That gap is the one part of this market a reader can actually close. How to read a certificate of analysis covers the five measures in five minutes, and the 2026 audit grades vendors on the documents they publish against a rubric printed in full.

Questions we get

What is Epithalon used for?

On the human record, nothing yet. It is sold for telomere lengthening and anti-aging. The published support is cell culture, where epitalon raises hTERT and lengthens telomeres in human cells ¹⁵.

The rest is one lifetime mouse study in which average lifespan did not change ⁴. No trial has given this peptide to a person and measured an outcome.

How is Epithalon used?

Descriptively, and not as guidance: subcutaneous injection from a reconstituted vial, in short courses of 10 to 20 days repeated once or twice a year. That pattern comes from forums and vendor protocol pages, not from a study.

The only published dosing for the peptide itself is in mice, about 30 to 40 micrograms per kilogram, five days a month, for life ⁴.

How long does Epithalon take to work?

Nothing in the literature says. No human trial measured onset. The claimed outcome, telomere length, produces no sensation, so there is nothing a person could feel that would confirm it. The Russian clinical courses ran for years before mortality was counted, and those courses used a different preparation ²³.

Is Epithalon the same thing as Epithalamin?

No, and the difference carries most of the marketing. Epithalamin is a bovine pineal extract, a mixture. Epithalon is one synthetic tetrapeptide drawn from that idea.

The human studies quoted for Epithalon dosed the extract ²³. That is 266 older adults with mortality down 1.6 to 1.8-fold, and a 12-year study in elderly cardiac patients.

Has any Western group replicated this?

Partly, and only in cells. A 2025 Brunel University study found dose-dependent telomere lengthening in normal human cell lines, through hTERT and telomerase ⁵.

In cancer cell lines it also lengthened telomeres, through an alternative pathway ⁵. That is the first independent confirmation of the cell-culture claim. No group outside St Petersburg has repeated the clinical work.

References

Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135:590-592. PMID 12937682
Khavinson VKh, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett. 2003;24:233-240. PMID 14523363
Korkushko OV, Khavinson VKh, Shatilo VB, Antonyuk-Shcheglova IA. Geroprotective effect of epithalamine [pineal gland peptide preparation] in elderly subjects with accelerated aging. Bull Exp Biol Med. 2006;142:356-359. PMID 17426848
Anisimov VN, Khavinson VKh, Popovich IG, et al. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. 2003;4:193-202. PMID 14501183
Al-Dulaimi S, Thomas R, Matta S, Roberts T. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology. 2025;26:178. PMID 40908429
Korkushko OV, Khavinson VKh, Shatilo VB, Magdich LV. Effect of peptide preparation epithalamin on circadian rhythm of epiphyseal melatonin-producing function in elderly people. Bull Exp Biol Med. 2004;137:389-391. PMID 15452611
Khavinson V, Diomede F, Mironova E, et al. AEDG peptide [Epitalon] stimulates gene expression and protein synthesis during neurogenesis: possible epigenetic mechanism. Molecules. 2020;25:609. PMID 32019204
Araj SK, Szelenberger R, Bijak M, et al. Overview of Epitalon, a highly bioactive pineal tetrapeptide with promising properties. Int J Mol Sci. 2025;26:2691. PMID 40141333
Khavinson VKh, Bondarev IE, Butyugov AA, Smirnova TD. Peptide promotes overcoming of the division limit in human somatic cell. Bull Exp Biol Med. 2004;137:503-506. PMID 15455129
US Food and Drug Administration. Certain bulk drug substances for use in compounding may present significant safety risks. Accessed 24 Aug 2026. fda.gov

Inside Your Peptides is published by the owners of the next lab, a vendor graded elsewhere on this site. We sell nothing here, and this page carries no vendor link. Grades follow the published criteria in our editorial policy — never referral terms. Research and education only. Not medical advice.